Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Liabilities from Discontinued Operations (2018 - 2019)

Sunshine Biopharma filings provide 2 years of Liabilities from Discontinued Operations readings, the most recent being 103732.0 for Q2 2019.

  • On a quarterly basis, Liabilities from Discontinued Operations changed N/A to 103732.0 in Q2 2019 year-over-year; TTM through Jun 2019 was 103732.0, a N/A change, with the full-year FY2018 number at 103732.0, changed N/A from a year prior.
  • Liabilities from Discontinued Operations hit 103732.0 in Q2 2019 for Sunshine Biopharma, roughly flat from 103732.0 in the prior quarter.
  • In the past five years, Liabilities from Discontinued Operations ranged from a high of 103732.0 in Q4 2018 to a low of 103732.0 in Q4 2018.